726 related articles for article (PubMed ID: 28520851)
21. A case of post kala-azar dermal leishmaniasis in India.
Tripathy K; Misra A; Mallik R; Misra D; Rout N; Rath J
Korean J Parasitol; 2010 Sep; 48(3):245-6. PubMed ID: 20877504
[TBL] [Abstract][Full Text] [Related]
22. Revisiting the role of the slit-skin smear in the diagnosis of Indian post-kala-azar dermal leishmaniasis.
Bhargava A; Ramesh V; Verma S; Salotra P; Bala M
Indian J Dermatol Venereol Leprol; 2018; 84(6):690-695. PubMed ID: 30058565
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Recombinase Polymerase Amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis.
Roy M; Ceruti A; Kobialka RM; Roy S; Sarkar D; Wahed AAE; Chatterjee M
PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011231. PubMed ID: 37075066
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
Mathur P; Samantaray J; Chauhan NK
Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
[TBL] [Abstract][Full Text] [Related]
25. Real-Time Fluorimetry Loop-Mediated Isothermal Amplification for Diagnosis of Leishmaniasis and as a Tool for Assessment of Cure for Post-Kala-Azar Dermal Leishmaniasis.
Dixit KK; Ramesh V; Gupta R; Negi NS; Singh R; Salotra P
Am J Trop Med Hyg; 2021 Apr; 104(6):2097-2107. PubMed ID: 33872204
[TBL] [Abstract][Full Text] [Related]
26. Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.
Zijlstra EE; Alves F; Rijal S; Arana B; Alvar J
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0005877. PubMed ID: 29145397
[TBL] [Abstract][Full Text] [Related]
27. Assessing the Efficacy and Safety of Liposomal Amphotericin B and Miltefosine in Combination for Treatment of Post Kala-Azar Dermal Leishmaniasis.
Ramesh V; Dixit KK; Sharma N; Singh R; Salotra P
J Infect Dis; 2020 Feb; 221(4):608-617. PubMed ID: 31854451
[TBL] [Abstract][Full Text] [Related]
28. Visceral leishmaniasis in India: promises and pitfalls of a PCR-based blood test.
Adhya S; Hassan MQ; Mukherjee S; Manna PP; Basu A; Sen S; Bandyopadhyay S
Trans R Soc Trop Med Hyg; 2002 Apr; 96 Suppl 1():S179-83. PubMed ID: 12055835
[TBL] [Abstract][Full Text] [Related]
29. Nested PCR assay for detection of Leishmania donovani in slit aspirates from post-kala-azar dermal Leishmaniasis Lesions.
Sreenivas G; Ansari NA; Kataria J; Salotra P
J Clin Microbiol; 2004 Apr; 42(4):1777-8. PubMed ID: 15071047
[TBL] [Abstract][Full Text] [Related]
30. Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India.
Subba Raju BV; Gurumurthy S; Kuhls K; Bhandari V; Schnonian G; Salotra P
Parasitol Res; 2012 Oct; 111(4):1559-68. PubMed ID: 22752721
[TBL] [Abstract][Full Text] [Related]
31. Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis.
Hasnain G; Shomik MS; Ghosh P; Rashid MO; Hossain S; Hamano S; Mondal D
Am J Trop Med Hyg; 2016 Dec; 95(6):1383-1385. PubMed ID: 27672208
[TBL] [Abstract][Full Text] [Related]
32. An experimental study on application of PCR in detection of kala-azar.
Wu Z; Bao Y; Ding Y; Yu M; Lu L; Zhang Y
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):169-72. PubMed ID: 9322302
[TBL] [Abstract][Full Text] [Related]
33. An In-depth Proteomic Map of Leishmania donovani Isolate from Post Kala-azar Dermal Leishmaniasis (PKDL) Patient.
Routaray CB; Kumar A; Sundar S; Sathe G; Pawar H; Pai K
Acta Parasitol; 2022 Jun; 67(2):687-696. PubMed ID: 35020128
[TBL] [Abstract][Full Text] [Related]
34. The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC).
Gasim S; Elhassan AM; Kharazmi A; Khalil EA; Ismail A; Theander TG
Clin Exp Immunol; 2000 Mar; 119(3):523-9. PubMed ID: 10691926
[TBL] [Abstract][Full Text] [Related]
35. Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment.
Hossain F; Ghosh P; Khan MAA; Duthie MS; Vallur AC; Picone A; Howard RF; Reed SG; Mondal D
PLoS One; 2017; 12(9):e0185606. PubMed ID: 28957391
[TBL] [Abstract][Full Text] [Related]
36. PCR-based detection of Leishmania DNA in skin samples of post kala-azar dermal leishmaniasis patients from an endemic area of Bangladesh.
Nasreen SA; Hossain MA; Paul SK; Mahmud MC; Ahmed S; Ghosh S; Kobayashi N
Jpn J Infect Dis; 2012 Jul; 65(4):315-7. PubMed ID: 22814154
[TBL] [Abstract][Full Text] [Related]
37. Comparative in vivo expression of amastigote up regulated Leishmania genes in three different forms of Leishmaniasis.
Sharma P; Gurumurthy S; Duncan R; Nakhasi HL; Salotra P
Parasitol Int; 2010 Jun; 59(2):262-4. PubMed ID: 19963076
[TBL] [Abstract][Full Text] [Related]
38. Kala-azar and post-kala-azar dermal leishmaniasis, Assam, India.
Khan AM; Dutta P; Khan SA; Baruah SK; Raja D; Khound K; Mahanta J
Emerg Infect Dis; 2014 Mar; 20(3):487-9. PubMed ID: 24565057
[No Abstract] [Full Text] [Related]
39. Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.
Ramesh V; Kaushal H; Mishra AK; Singh R; Salotra P
BMC Public Health; 2015 Oct; 15():1092. PubMed ID: 26503551
[TBL] [Abstract][Full Text] [Related]
40. Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: a possible challenge to elimination program in India.
Das VN; Pandey K; Singh D; Forwood C; Lal CS; Das P
J Postgrad Med; 2013; 59(3):226-8. PubMed ID: 24029204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
